CN Stock MarketDetailed Quotes
300289 Beijing Leadman Biochemistry
- 5.22
- +0.04+0.77%
Trading Nov 15 13:31 CST
2.84BMarket Cap-372857P/E (TTM)
5.27High5.15Low48.13KlotVolume5.18Open5.18Pre Close25.05MTurnover0.89%Turnover Ratio186.43P/E (Static)544.01MShares6.6052wk High1.63P/B2.84BFloat Cap3.4452wk Low6.22Limit Up543.16MShs Float30.76Historical High4.14Limit Down2.32%Amplitude3.44Historical Low0.01Dividend TTM5.21Avg Price26.55KlotAsk0.19%Div YieldTTM100Lot Size21.10KlotBid
Beijing Leadman Biochemistry Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -16.40%360.77M | -17.46%232.34M | -6.70%126.81M | -30.86%557.33M | -34.19%431.55M | -38.07%281.5M | -44.49%135.92M | 26.47%806.05M | 27.31%655.78M | 39.57%454.53M |
| Refunds of taxes and levies | --500.55K | --478.03K | ---- | ---- | ---- | ---- | ---- | --133.27K | -70.59%327.19K | 156.00%302.12K |
| Net deposit increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in borrowings from central bank | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in placements from other financial institutions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received from interests, fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in repurchase business capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Premiums received from original insurance contracts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net cash received from reinsurance business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in deposits from policyholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net increase in funds disbursed | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net cash received from trading securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received relating to other operating activities | -32.36%10.19M | -13.29%9.19M | -38.65%4.11M | 24.57%21.68M | 29.30%15.06M | 39.81%10.6M | 69.53%6.7M | 10.36%17.4M | 20.45%11.65M | 11.36%7.58M |
| Cash inflows from operating activities | -16.83%371.46M | -17.15%242.01M | -8.20%130.92M | -29.70%579.01M | -33.12%446.61M | -36.83%292.1M | -42.68%142.62M | 26.10%823.59M | 26.97%667.75M | 39.03%462.41M |
| Goods services cash paid | 10.52%130.95M | 6.78%82.08M | 42.48%48.26M | -65.27%153.26M | -68.40%118.48M | -69.58%76.87M | -80.49%33.88M | 54.59%441.23M | 36.49%374.89M | 61.28%252.68M |
| Staff behalf paid | 0.80%102.04M | -2.85%73.51M | -9.24%41.49M | 5.69%133.94M | 5.14%101.23M | 6.54%75.67M | 16.96%45.72M | 5.60%126.73M | 0.68%96.28M | 2.74%71.03M |
| All taxes paid | -35.12%32.93M | -34.77%23.28M | -27.06%12.48M | 1.22%61.42M | 17.95%50.76M | 19.68%35.68M | 80.92%17.11M | -0.02%60.68M | -2.65%43.03M | 0.13%29.82M |
| Net loan and advance increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net deposit in central bank and institutions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Net lend capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid for fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid for indemnity of original insurance contract | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Policy dividend cash paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid relating to other operating activities | -3.19%58.85M | 5.61%39.01M | 9.57%20.17M | 15.79%99.6M | -19.21%60.8M | -15.32%36.94M | -17.45%18.41M | 26.66%86.02M | 21.17%75.25M | 20.85%43.62M |
| Cash outflows from operating activities | -1.96%324.77M | -3.23%217.88M | 6.34%122.41M | -37.28%448.21M | -43.80%331.27M | -43.30%225.16M | -52.91%115.11M | 33.82%714.66M | 23.68%589.46M | 36.16%397.14M |
| Net cash flows from operating activities | -59.52%46.69M | -63.95%24.14M | -69.06%8.51M | 20.07%130.8M | 47.32%115.34M | 2.56%66.94M | 535.02%27.51M | -8.50%108.93M | 58.81%78.3M | 59.55%65.27M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 130.77%600M | --490M | --180M | -14.29%540M | -21.21%260M | ---- | ---- | --630M | 931.25%330M | 931.25%330M |
| Cash received from returns on investments | 672.73%14.68M | --3.82M | --1.06M | -14.61%3.62M | -18.09%1.9M | ---- | ---- | 15,703.43%4.24M | 8,536.16%2.32M | 8,536.16%2.32M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --37K | --37K | --37K | ---- | ---- | ---- | ---- | -72.53%589.29K | -68.41%676.8K | -76.50%503.56K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash inflows from investing activities | 134.71%614.72M | --493.86M | --181.1M | -14.37%543.62M | -21.35%261.9M | ---- | ---- | 29,132.07%634.83M | 874.55%333M | 874.04%332.82M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 47.56%18.53M | 59.58%16.02M | 603.45%17.81M | -52.23%18.69M | -17.04%12.55M | -23.04%10.04M | -68.35%2.53M | -12.10%39.12M | -44.31%15.13M | -41.03%13.04M |
| Cash paid to acquire investments | 49.30%800M | 1.37%310M | ---- | 8.59%878.27M | -16.97%535.82M | -11.43%305.82M | -87.52%39.35M | --808.83M | 1,916.56%645.3M | 979.06%345.3M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Impawned loan net increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash outflows from investing activities | 49.26%818.53M | 3.22%326.02M | -57.48%17.81M | 5.78%896.96M | -16.97%548.37M | -11.86%315.86M | -87.05%41.88M | 1,805.39%847.95M | 1,016.13%660.43M | 562.14%358.34M |
| Net cash flows from investing activities | 28.86%-203.81M | 153.14%167.84M | 489.92%163.29M | -65.79%-353.33M | 12.51%-286.47M | -1,137.67%-315.86M | 87.03%-41.88M | -403.45%-213.11M | -1,209.62%-327.44M | -27.92%-25.52M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --950K | --950K | --950K | --1.5M | ---- | ---- | ---- | ---- | ---- | --0 |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --950K | --950K | --950K | --1.5M | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash from borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | --23.94K | --23.94K | -94.95%21.22K | -73.59%716.71K | ---- | --0 |
| Cash inflows from financing activities | 3,868.78%950K | 3,868.78%950K | 4,377.36%950K | 109.29%1.5M | --23.94K | --23.94K | -94.95%21.22K | -99.87%716.71K | ---- | --0 |
| Borrowing repayment | ---- | ---- | ---- | -26.86%7.93M | 5.15%7.93M | 5.12%5.25M | 5.21%2.61M | -78.25%10.84M | -82.76%7.54M | -88.58%5M |
| Dividend interest payment | 5,579.14%12.79M | 6,595.75%12.79M | ---- | -98.27%201.33K | -98.15%225.26K | -98.41%191.06K | -89.45%101.34K | 2,779.30%11.61M | 1,040.83%12.2M | 1,025.23%12.04M |
| -Including:Cash payments for dividends or profit to minority shareholders | --7.35M | --7.35M | ---- | ---- | ---- | ---- | ---- | --729.91K | --729.91K | --729.91K |
| Cash payments relating to other financing activities | 46.35%3.33M | 75.55%2.27M | 1,126.71%1.13M | 36.31%4.13M | -13.26%2.28M | -28.83%1.29M | -93.54%92.44K | -45.38%3.03M | 220.54%2.63M | --1.82M |
| Cash outflows from financing activities | 54.55%16.13M | 123.54%15.06M | -59.55%1.13M | -51.89%12.26M | -53.36%10.43M | -64.26%6.74M | -42.47%2.8M | -54.33%25.48M | -50.99%22.37M | -57.95%18.85M |
| Net cash flows from financing activities | -45.78%-15.18M | -110.19%-14.11M | 93.39%-184.02K | 56.55%-10.76M | 53.47%-10.41M | 64.38%-6.71M | 37.52%-2.78M | -104.96%-24.76M | -104.41%-22.37M | 56.74%-18.85M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | ---- | ---- | -272.97%-493.12K | ---- | ---- | ---- | -177.24%-132.21K | ---- | --0 |
| Net increase in cash and cash equivalents | 5.09%-172.29M | 169.58%177.86M | 1,100.59%171.62M | -81.13%-233.79M | 33.14%-181.54M | -1,323.09%-255.63M | 94.69%-17.15M | -122.41%-129.07M | -151.06%-271.51M | 192.42%20.9M |
| Add:Begin period cash and cash equivalents | -29.29%564.49M | -29.29%564.49M | -29.29%564.49M | -13.92%798.28M | -13.92%798.28M | -13.92%798.28M | -14.03%798.28M | 163.97%927.35M | 163.97%927.35M | 163.97%927.35M |
| End period cash equivalent | -36.41%392.19M | 36.80%742.35M | -5.76%736.11M | -29.29%564.49M | -5.96%616.74M | -42.77%542.65M | 28.99%781.13M | -13.92%798.28M | -25.73%655.84M | 188.49%948.25M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data